Delphian淋巴结转移在甲状腺乳头状癌中的临床意义
回顾性分析2015年1月至12月本院505例病理确诊甲状腺乳头状癌(PTC)中208例单独病理评估Delphian淋巴结(DLN)的原发手术患者。DLN检出率63.0%,转移率21.4%;DLN转移与多灶性、肿瘤>1cm、BRAFV600E突变及中央区淋巴结转移相关,肿瘤>1cm和中央区转移淋巴结数为独立危险因素。
要点
- 208例PTC患者DLN检出率63.0%,DLN转移率21.4%。
- DLN转移者中央区淋巴结转移频率为无DLN转移者的8.8倍。
- 肿瘤>1cm和中央区转移淋巴结数为DLN转移独立危险因素。
核心结论
- DLN转移提示中央区淋巴结转移可能性更高。
- 作者建议术中评估DLN,为颈淋巴结清扫、术后给药及随访策略提供信息。
研究设计与样本
- 回顾性分析2015年1月至2015年12月本院病理确诊的505例PTC,其中208例原发手术且DLN经组织病理学单独评估者纳入分析。
主要发现
- 208例中DLN检出率63.0%,DLN转移率21.4%。
- DLN转移与PTC多灶性(P=0.038)、肿瘤大小超过1cm(P=0.001)、BRAFV600E突变(P=0.017)及中央区淋巴结转移(P<0.001)相关。
- 肿瘤大小超过1cm(95%CI 1.308-9.909,OR=3.600,P=0.013)和中央区转移淋巴结数(95%CI 1.313-2.163,OR=1.685,P<0.001)为DLN转移的独立危险因素。
- 存在DLN转移者中央区淋巴结转移频率为无DLN转移者的8.8倍。
- DLN转移患者中,有侧颈淋巴结转移者中央区淋巴结转移数多于无侧颈淋巴结转移者(6.5±3.0 vs 1.5±0.7,P=0.009),且6例中有5例同时伴PTC多灶性和BRAFV600E突变。
临床怎么用
- 作者建议术中评估DLN,以期为颈淋巴结清扫、术后给药及随访策略提供信息。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To evaluate the clinical significance of Delphian lymph node (DLN) metastasis in papillary thyroid cancer (PTC). Method: A total of 505 cases with PTC confirmed pathologically in our hospital between January 2015 and December 2015 were retrospectively reviewed. 208 patients with DLN assessed separately by histopathologic examination who underwent primary surgery for PTC were included for the following analysis. Results: In 208 patients, the detection rate of DLN was 63.0% and the metastasis rate of DLN was 21.4%. DLN metastasis was correlated with PTC multifocality (P=0.038), tumor size over 1cm (P=0.001), BRAFV600E mutation (P=0.017) and central neck node metastasis (P<0.001). Tumor size over 1cm (95%CI 1.308-9.909, OR=3.600, P=0.013) and the number of node with central neck metastasis (95%CI 1.313-2.163, OR=1.685, P<0.001) were independent risk factors for DLN metastasis. The presence of DLN metastasis was associated with an 8.8-fold higher frequency of central neck node metastasis compared to cases without DLN metastasis. Among patients with DLN metastases, central lymph node metastasis was more common in the cases with lateral neck node metastases compared to those without lateral neck node metastases (6.5±3.0 vs 1.5±0.7, P=0.009), and 5 of the 6 patients also presented with PTC multifocality and BRAFV600E mutation. Conclusion: DLN metastasis implies a higher possibility of central neck lymph node metastasis. DLN should be assessed during operation to provide information for neck dissection, post-operative administration and follow-up strategy.
引用
- Zheng GB, Hao SL, Liu XC, et al. [The clinical significance of Delphian lymph node metastasis in papillary thyroid cancer]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016. PMID: 27938611. doi:10.3760/cma.j.issn.1673-0860.2016.11.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。